Teleflex Incorporated (NYSE:TFX) Shares Sold by AXQ Capital LP

AXQ Capital LP trimmed its stake in Teleflex Incorporated (NYSE:TFX) by 39.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,892 shares of the medical technology company’s stock after selling 1,904 shares during the period. AXQ Capital LP’s holdings in Teleflex were worth $515,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Avior Wealth Management LLC boosted its holdings in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares during the period. True Wealth Design LLC grew its position in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares in the last quarter. IFP Advisors Inc grew its position in Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 217 shares in the last quarter. Banque Cantonale Vaudoise raised its stake in Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares during the period. Finally, Exchange Traded Concepts LLC lifted its holdings in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on TFX. Truist Financial lowered their price target on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Wells Fargo & Company reduced their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Finally, Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Teleflex presently has a consensus rating of “Hold” and a consensus price target of $182.63.

Teleflex Price Performance

NYSE TFX opened at $141.77 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $6.57 billion, a PE ratio of 28.19, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.91. The company has a 50 day moving average price of $163.17 and a two-hundred day moving average price of $194.04.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, equities analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.